{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:16:29Z","timestamp":1794028589520,"version":"4.8.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.coviro.2020.09.001","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T19:29:59Z","timestamp":1600370999000},"page":"50-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Dengue mouse models for evaluating pathogenesis and countermeasures"],"prefix":"10.1016","volume":"43","author":[{"given":"Rita E","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2020.09.001_bib0005","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1128\/CMR.11.3.480","article-title":"Dengue and dengue hemorrhagic fever","volume":"11","author":"Gubler","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.coviro.2020.09.001_bib0010","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2020.09.001_bib0015","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/00034983.1957.11685829","article-title":"Genetical aspects of the Aedes aegypti problem. I. Taxonom: and bionomics","volume":"51","author":"Mattingly","year":"1957","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0020","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1128\/MMBR.00024-15","article-title":"Deconstructing the antiviral neutralizing-antibody response: implications for vaccine development and immunity","volume":"80","author":"VanBlargan","year":"2016","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.coviro.2020.09.001_bib0025","doi-asserted-by":"crossref","first-page":"e1760","DOI":"10.1371\/journal.pntd.0001760","article-title":"Refining the global spatial limits of dengue virus transmission by evidence-based consensus","volume":"6","author":"Brady","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2020.09.001_bib0030","series-title":"Flaviviruses, in Fields Virology: Sixth Edition","author":"Pierson","year":"2013"},{"key":"10.1016\/j.coviro.2020.09.001_bib0035","series-title":"Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control: New Edition","author":"WHO Guidelines Approved by the Guidelines Review Committee","year":"2009"},{"key":"10.1016\/j.coviro.2020.09.001_bib0040","first-page":"311","article-title":"Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered","volume":"42","author":"Halstead","year":"1970","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.coviro.2020.09.001_bib0045","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4269\/ajtmh.1997.56.566","article-title":"Risk factors in dengue shock syndrome","volume":"56","author":"Thein","year":"1997","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.coviro.2020.09.001_bib0050","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/oxfordjournals.aje.a113932","article-title":"Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak","volume":"120","author":"Sangkawibha","year":"1984","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0055","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.coviro.2020.09.001_bib0060","first-page":"24","article-title":"Immunological enhancement of dengue virus replication","volume":"243","author":"Halstead","year":"1973","journal-title":"Nat New Biol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0065","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/imr.12367","article-title":"Fc receptors in antibody-dependent enhancement of viral infections","volume":"268","author":"Taylor","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coviro.2020.09.001_bib0070","doi-asserted-by":"crossref","first-page":"e617","DOI":"10.1371\/journal.pntd.0000617","article-title":"Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006","volume":"4","author":"Fried","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2020.09.001_bib0075","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3201\/eid0812.020170","article-title":"Dengue hemorrhagic fever in infants: research opportunities ignored","volume":"8","author":"Halstead","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.coviro.2020.09.001_bib0080","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S1473-3099(16)00146-8","article-title":"The global economic burden of dengue: a systematic analysis","volume":"16","author":"Shepard","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coviro.2020.09.001_bib0085","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1473-3099(16)00026-8","article-title":"The global burden of dengue: an analysis from the Global Burden of Disease Study 2013","volume":"16","author":"Stanaway","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coviro.2020.09.001_bib0090","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.4269\/ajtmh.18-0309","article-title":"Impact of a nonfatal dengue episode on disability-adjusted life years: a systematic analysis","volume":"99","author":"Zeng","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.coviro.2020.09.001_sbref0095","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"New Engl J Med"},{"key":"10.1016\/j.coviro.2020.09.001_bib0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/infdis\/128.1.7","article-title":"Studies on the pathogenesis of dengue infection in monkeys. I. Clinical laboratory responses to primary infection","volume":"128","author":"Halstead","year":"1973","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.09.001_bib0105","first-page":"97","article-title":"Models of dengue virus infection. Drug discovery today","volume":"3","author":"Bente","year":"2006","journal-title":"Dis Models"},{"key":"10.1016\/j.coviro.2020.09.001_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/90.1.1","article-title":"Experimental studies on dengue. I. Isolation, identification and modification of the virus","volume":"90","author":"Hotta","year":"1952","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.09.001_bib0115","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1128\/JVI.02514-09","article-title":"Dengue virus inhibits the production of type I interferon in primary human dendritic cells","volume":"84","author":"Rodriguez-Madoz","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0120","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.chom.2010.10.007","article-title":"Mouse STAT2 restricts early dengue virus replication","volume":"8","author":"Ashour","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2020.09.001_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002934","article-title":"DENV inhibits type I IFN production in infected cells by cleaving human STING","volume":"8","author":"Aguirre","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.09.001_bib0130","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/jmv.20108","article-title":"Lymphocyte activation and hepatic cellular infiltration in immunocompetent mice infected by dengue virus","volume":"73","author":"Chen","year":"2004","journal-title":"J Med Virol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0135","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1128\/JVI.02575-06","article-title":"Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage","volume":"81","author":"Chen","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0140","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/1743-422X-8-398","article-title":"Phenotypic characterization of patient dengue virus isolates in BALB\/c mice differentiates dengue fever and dengue hemorrhagic fever from dengue shock syndrome","volume":"8","author":"Tuiskunen","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.coviro.2020.09.001_bib0145","doi-asserted-by":"crossref","first-page":"14138","DOI":"10.1073\/pnas.0906467106","article-title":"Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection","volume":"106","author":"Souza","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2020.09.001_bib0150","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/imm.12988","article-title":"Interleukin-33 contributes to disease severity in Dengue virus infection in mice","volume":"155","author":"Marques","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.coviro.2020.09.001_bib0155","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/imm.12476","article-title":"Dengue virus requires the CC-chemokine receptor CCR5 for replication and infection development","volume":"145","author":"Marques","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.coviro.2020.09.001_bib0160","doi-asserted-by":"crossref","first-page":"e1663","DOI":"10.1371\/journal.pntd.0001663","article-title":"A model of DENV-3 infection that recapitulates severe disease and highlights the importance of IFN-\u03b3 in host resistance to infection","volume":"6","author":"Costa","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2020.09.001_bib0165","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3389\/fimmu.2019.01429","article-title":"Dengue mosaic vaccines enhance cellular immunity and expand the breadth of neutralizing antibody against all four serotypes of dengue viruses in mice","volume":"10","author":"Hou","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0170","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1016\/j.vaccine.2020.03.008","article-title":"Comparison of purified psoralen-inactivated and formalin-inactivated dengue vaccines in mice and nonhuman primates","volume":"38","author":"Sundaram","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2020.09.001_bib0175","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pep.2019.05.005","article-title":"Expression and purification of domain III proteins from Dengue and Zika viruses","volume":"162","author":"Corzo-G\u00f3mez","year":"2019","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.coviro.2020.09.001_bib0180","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fcimb.2019.00147","article-title":"Cross-protection against four serotypes of dengue virus in mice conferred by a Zika DNA vaccine","author":"Wang","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0185","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3389\/fmicb.2019.01113","article-title":"Vaccination with a single consensus envelope protein ectodomain sequence administered in a heterologous regimen induces tetravalent immune responses and protection against dengue viruses in mice","volume":"10","author":"Wang","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104560","article-title":"Intraperitoneal injection with dengue virus type 1-infected K562 cells results in complete fatality among immunocompetent mice","volume":"170","author":"Yamanaka","year":"2019","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.09.001_bib0195","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.vaccine.2019.10.075","article-title":"Construction of a novel tetravalent dengue vaccine with a Salmonella Typhimurium bacterial ghost and evaluation of its immunogenicity and protective efficacy using a murine model","volume":"38","author":"Kim","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2020.09.001_bib0200","doi-asserted-by":"crossref","first-page":"90","DOI":"10.24272\/j.issn.2095-8137.2020.016","article-title":"Long-term protection against dengue viruses in mice conferred by a tetravalent DNA vaccine candidate","volume":"41","author":"Wang","year":"2020","journal-title":"Zool Res"},{"key":"10.1016\/j.coviro.2020.09.001_bib0205","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S1474-4422(13)70150-9","article-title":"Neurological complications of dengue virus infection","volume":"12","author":"Carod-Artal","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.coviro.2020.09.001_sbref0210","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-54474-7","article-title":"Dengue infection in mice inoculated by the intracerebral route: neuropathological effects and identification of target cells for virus replication","volume":"9","author":"Amorim","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.coviro.2020.09.001_sbref0215","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.celrep.2019.01.036","article-title":"Flavivirus NS1 triggers tissue-specific vascular endothelial dysfunction reflecting disease tropism","volume":"26","author":"Puerta-Guardo","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.coviro.2020.09.001_sbref0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007625","article-title":"Dengue virus nonstructural protein 1 activates platelets via toll-like receptor 4, leading to thrombocytopenia and hemorrhage","volume":"15","author":"Chao","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.09.001_bib0225","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/JVI.73.1.783-786.1999","article-title":"New mouse model for dengue virus vaccine testing","volume":"73","author":"Johnson","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125476","article-title":"A dengue virus Type 4 model of disseminated lethal infection in AG129 mice","volume":"10","author":"Milligan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2020.09.001_bib0235","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1099\/jgv.0.000246","article-title":"Characterization of lethal dengue virus type 4 (DENV-4) TVP-376 infection in mice lacking both IFN-\u03b1\/\u03b2 and IFN-\u03b3 receptors (AG129) and comparison with the DENV-2 AG129 mouse model","volume":"96","author":"Sarathy","year":"2015","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0240","doi-asserted-by":"crossref","first-page":"10208","DOI":"10.1128\/JVI.00062-06","article-title":"Murine model for dengue virus-induced lethal disease with increased vascular permeability","volume":"80","author":"Shresta","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0245","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1128\/JVI.01320-14","article-title":"A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease","volume":"89","author":"Sarathy","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0250","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1099\/jgv.0.000923","article-title":"A lethal model of disseminated dengue virus type 1 infection in AG129 mice","volume":"98","author":"Milligan","year":"2017","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2020.09.001_sbref0255","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-22618-w","article-title":"Characterization of a murine model of non-lethal, symptomatic dengue virus infection","volume":"8","author":"Sarathy","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.coviro.2020.09.001_bib0260","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.chom.2010.01.004","article-title":"Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease","volume":"7","author":"Zellweger","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2020.09.001_bib0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000790","article-title":"Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification","volume":"6","author":"Balsitis","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.09.001_bib0270","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftz026","article-title":"Pichia pastoris-expressed Zika virus envelope domain III on a virus-like particle platform: design, production and immunological evaluation","volume":"77","author":"Shanmugam","year":"2019","journal-title":"Pathog Dis"},{"key":"10.1016\/j.coviro.2020.09.001_bib0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102738","article-title":"Zika virus envelope nanoparticle antibodies protect mice without risk of disease enhancement","volume":"54","author":"Shukla","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coviro.2020.09.001_sbref0280","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat7726","article-title":"A T164S mutation in the dengue virus NS1 protein is associated with greater disease severity in mice","volume":"11","author":"Chan","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coviro.2020.09.001_bib0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007836","article-title":"A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain III","volume":"15","author":"Hu","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.09.001_bib0290","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00705-020-04524-7","article-title":"The small molecule AZD6244 inhibits dengue virus replication in vitro and protects against lethal challenge in a mouse model","volume":"165","author":"de Oliveira","year":"2020","journal-title":"Arch Virol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0295","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.antiviral.2018.04.012","article-title":"Spectrum of activity testing for therapeutics against all four dengue virus serotypes in AG129 mouse models: proof-of-concept studies with the adenosine nucleoside inhibitor NITD-008","volume":"154","author":"Milligan","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.09.001_bib0300","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1021\/acsinfecdis.8b00054","article-title":"Preclinical antiviral testing for dengue virus infection in mouse models and its association with clinical studies","volume":"4","author":"Watanabe","year":"2018","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.coviro.2020.09.001_bib0305","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.antiviral.2017.03.026","article-title":"Luteolin restricts dengue virus replication through inhibition of the proprotein convertase furin","volume":"143","author":"Peng","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.09.001_bib0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2018.07.022","article-title":"Synergism between the tyrosine kinase inhibitor sunitinib and Anti-TNF antibody protects against lethal dengue infection","volume":"158","author":"Branche","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.09.001_bib0315","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.antiviral.2018.05.001","article-title":"Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment","volume":"155","author":"Pu","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2020.09.001_bib0320","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1099\/vir.0.045088-0","article-title":"Characterization of a model of lethal dengue virus 2 infection in C57BL\/6 mice deficient in the alpha\/beta interferon receptor","volume":"93","author":"Orozco","year":"2012","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0325","doi-asserted-by":"crossref","first-page":"12561","DOI":"10.1128\/JVI.06743-11","article-title":"Gamma interferon (IFN-\u03b3) receptor restricts systemic dengue virus replication and prevents paralysis in IFN-\u03b1\/\u03b2 receptor-deficient mice","volume":"86","author":"Prestwood","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0330","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1128\/JVI.78.6.2701-2710.2004","article-title":"Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical","volume":"78","author":"Shresta","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0335","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1099\/jgv.0.001319","article-title":"Increased serum sialic acid is associated with morbidity and mortality in a murine model of dengue disease","volume":"100","author":"Espinosa","year":"2019","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0340","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00996-19","article-title":"Dengue virus M protein promotes NLRP3 inflammasome activation to induce vascular leakage in mice","volume":"93","author":"Pan","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0345","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01316-15","article-title":"Defining new therapeutics using a more immunocompetent mouse model of antibody-enhanced dengue virus infection","volume":"6","author":"Pinto","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2020.09.001_bib0350","article-title":"Mimicking immune signatures of flavivirus infection with targeted adjuvants improves dengue subunit vaccine immunogenicity","volume":"4","author":"Bidet","year":"2019","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.coviro.2020.09.001_bib0355","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01002-18","article-title":"Using a virion assembly-defective dengue virus as a vaccine approach","volume":"92","author":"Shan","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.09.001_sbref0360","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-10360-4","article-title":"Extracellular vesicles from CLEC2-activated platelets enhance dengue virus-induced lethality via CLEC5A\/TLR2","volume":"10","author":"Sung","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2020.09.001_bib0365","doi-asserted-by":"crossref","first-page":"7051","DOI":"10.1016\/j.vaccine.2015.09.112","article-title":"Mouse models of dengue virus infection for vaccine testing","volume":"33","author":"Sarathy","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2020.09.001_bib0370","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4269\/ajtmh.1995.52.468","article-title":"Evaluation of the severe combined immunodeficient (SCID) mouse as an animal model for dengue viral infection","volume":"52","author":"Wu","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.coviro.2020.09.001_bib0375","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/viro.1999.9887","article-title":"Development of a novel mouse model for dengue virus infection","volume":"263","author":"An","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2020.09.001_bib0380","doi-asserted-by":"crossref","first-page":"13797","DOI":"10.1128\/JVI.79.21.13797-13799.2005","article-title":"Dengue fever in humanized NOD\/SCID mice","volume":"79","author":"Bente","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0385","article-title":"Humanized mice in dengue research: a comparison with other mouse models","volume":"8","author":"Coronel-Ruiz","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.coviro.2020.09.001_bib0390","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3389\/fimmu.2019.01424","article-title":"A modified mRNA vaccine targeting immunodominant NS Epitopes protects against dengue virus infection in HLA class I transgenic mice","volume":"10","author":"Roth","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0395","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/JLB.MA1217-484R","article-title":"Anti-TNF-\u03b1 restricts dengue virus-induced neuropathy","volume":"104","author":"Jhan","year":"2018","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0400","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07008-0","article-title":"Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model","volume":"9","author":"Bailey","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2020.09.001_bib0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006258","article-title":"A novel Zika virus mouse model reveals strain specific differences in virus pathogenesis and host inflammatory immune responses","volume":"13","author":"Tripathi","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.09.001_bib0410","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.chom.2018.04.003","article-title":"An immunocompetent mouse model of Zika virus infection","volume":"23","author":"Gorman","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2020.09.001_bib0415","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01034-19","article-title":"Genetic diversity of collaborative cross mice controls viral replication, clinical severity, and brain pathology induced by Zika virus infection, independently of Oas1b","volume":"94","author":"Manet","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0420","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.tig.2018.07.005","article-title":"Giving the genes a shuffle: using natural variation to understand host genetic contributions to viral infections","volume":"34","author":"Leist","year":"2018","journal-title":"Trends Genet"},{"key":"10.1016\/j.coviro.2020.09.001_bib0425","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.chom.2019.03.009","article-title":"The collaborative cross: a systems genetics resource for studying host-pathogen interactions","volume":"25","author":"Noll","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2020.09.001_bib0430","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/infdis\/4.3.440","article-title":"Experimental investigations regarding the etiology of dengue fever","volume":"4","author":"Ashburn","year":"1907","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.09.001_bib0435","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4269\/ajtmh.1952.1.30","article-title":"Research on dengue during World War II","volume":"1","author":"Sabin","year":"1952","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.coviro.2020.09.001_bib0440","article-title":"A review on dengue vaccine development","volume":"8","author":"Deng","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.coviro.2020.09.001_bib0445","series-title":"Janeway\u2019s Immunobiology","author":"Murphy","year":"2016"},{"key":"10.1016\/j.coviro.2020.09.001_bib0450","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2017.37","article-title":"Dengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection","volume":"2","author":"Aguirre","year":"2017","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0455","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00553-15","article-title":"Dengue virus NS proteins inhibit RIG-I\/MAVS signaling by blocking TBK1\/IRF3 phosphorylation: dengue virus serotype 1 NS4A is a unique interferon-regulating virulence determinant","volume":"6","author":"Dalrymple","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2020.09.001_bib0460","doi-asserted-by":"crossref","first-page":"8004","DOI":"10.1128\/JVI.79.13.8004-8013.2005","article-title":"Inhibition of alpha\/beta interferon signaling by the NS4B protein of flaviviruses","volume":"79","author":"Mu\u00f1oz-Jord\u00e1n","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0465","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1007\/s00253-019-09798-9","article-title":"Japanese encephalitis virus prM-E antigen immunization conferred protection against challenge by four different serotypes of Dengue viruses in mice","volume":"103","author":"Gao","year":"2019","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0470","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3389\/fimmu.2019.01522","article-title":"T cell responses induced by DNA vaccines based on the DENV2 E and NS1 proteins in mice: importance in protection and immunodominant epitope identification","volume":"10","author":"Pinto","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0475","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1182\/blood-2018-08-869156","article-title":"Peripheral serotonin causes dengue virus-induced thrombocytopenia through 5HT(2) receptors","volume":"133","author":"Masri","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2020.09.001_bib0480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007033","article-title":"Macrophage migration inhibitory factor is critical for dengue NS1-induced endothelial glycocalyx degradation and hyperpermeability","volume":"14","author":"Chen","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.09.001_bib0485","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.4049\/jimmunol.1900136","article-title":"Combination of modified NS1 and NS3 as a novel vaccine strategy against dengue virus infection","volume":"203","author":"Kao","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0490","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.3390\/ijms21114050","article-title":"Antiviral activity of compound L3 against Dengue and Zika Viruses in vitro and in vivo","volume":"21","author":"Chuang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coviro.2020.09.001_bib0495","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00941-19","article-title":"Anti-inflammatory Compound shows therapeutic safety and efficacy against Flavivirus infection","volume":"64","author":"Chuang","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2020.09.001_bib0500","article-title":"Addition of partial envelope Domain II into envelope Domain III of dengue virus antigen potentiates the induction of virus-neutralizing antibodies and induces protective immunity","volume":"8","author":"Park","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.coviro.2020.09.001_bib0505","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01023-18","article-title":"Engineered Dengue virus Domain III proteins elicit cross-neutralizing antibody responses in mice","volume":"92","author":"Frei","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0510","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.02644","article-title":"Pichia pastoris-expressed bivalent virus-like particulate vaccine induces Domain III-focused bivalent neutralizing antibodies without antibody-dependent enhancement in vivo","volume":"8","author":"Shukla","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.coviro.2020.09.001_sbref0515","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-26904-5","article-title":"Dengue envelope-based \u2018four-in-one\u2019 virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising antibodies in mice","volume":"8","author":"Rajpoot","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.coviro.2020.09.001_bib0520","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00546","article-title":"Immunodomination of serotype-specific CD4+ T-cell epitopes contributed to the biased immune responses induced by a tetravalent measles-vectored dengue vaccine","volume":"11","author":"Lin","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0525","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3390\/vaccines7040189","article-title":"Efficient delivery of Dengue virus subunit vaccines to the skin by microprojection arrays","volume":"7","author":"Muller","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.coviro.2020.09.001_bib0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006191","article-title":"A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice","volume":"12","author":"Ramasamy","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2020.09.001_sbref0535","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax7989","article-title":"Flavivirus induces and antagonizes antiviral RNA interference in both mammals and mosquitoes","volume":"6","author":"Qiu","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.coviro.2020.09.001_bib0540","article-title":"Nucleoside analogs with selective antiviral activity against dengue fever and Japanese encephalitis viruses","volume":"63","author":"Zandi","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2020.09.001_sbref0545","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41591-019-0746-2","article-title":"Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor","volume":"26","author":"Dussupt","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2020.09.001_bib0550","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.3389\/fmicb.2019.02637","article-title":"Dengue virus infection activates interleukin-1\u03b2 to Induce tissue injury and vascular leakage","volume":"10","author":"Pan","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.coviro.2020.09.001_bib0555","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.4049\/jimmunol.1801323","article-title":"Cyclic dinucleotide-adjuvanted dengue virus nonstructural protein 1 induces protective antibody and T cell responses","volume":"202","author":"Espinosa","year":"2019","journal-title":"J Immunol"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625720300894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625720300894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:04:25Z","timestamp":1761818665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625720300894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":111,"alternative-id":["S1879625720300894"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2020.09.001","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dengue mouse models for evaluating pathogenesis and countermeasures","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2020.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}